Pathway Health: Developing Their Proprietary my spark™ Platform

December 9, 2021

One of the largest providers of out-of-hospital pain management services in Canada

Pathway Health is committed to delivering personalized care to help improve a patients' quality of life. They strive to provide patients with timely access to personalized treatment plans using advanced and clinically-proven solutions to achieve the best outcomes.

Pathway Health Innovations is investing in the development of its proprietary my spark™ platform to support its business objectives. 
The my spark™ platform connects with and orchestrates several microservices and 3rd party platforms. It provides patients and Pathway Health's clinic team tools for tracking a variety of biomarkers and other health-related information, actionable insights driven by AI and big data,  as well as rewards for participating in studies.  These and other innovations make the my spark™ platform a key component of a scalable model for implementing thousands of pharmacies across Canada as well as supporting our diverse and extensive patient base and clinic network.

For more information on Pathway Health Corp. (TSX.V: PHC) please click the request investor info button.

You might also like

Healthcare
Defence Therapeutics: Revolutionizing Immune-Related Therapies with ACCUM Technology

Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology.

Healthcare
Investor Alert - Defence Therapeutics: Developing Immune-related Therapies for Cancer Treatment

Defence Therapeutics is a Canadian biotech company developing immune-related therapies for cancer treatment, including cancer vaccines, antibodies, and drug delivery vehicles.

Content Broadcast on: BNN Bloomberg, CNBC, Bloomberg, FOX Business News, BIZTV, Reuters, YouTube and more!